JB
SGYP

Julian Baker’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Julian Baker’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-67,100
Closed -$356K – 139
2015
Q3 		$356K Buy
+67,100
New +$519K ﹤0.01% 128
2015
Q1 		– Sell
-973,245
Closed -$2.97M – 135
2014
Q4 		$2.97M Hold
973,245
– – 0.03% 87
2014
Q3 		$2.71M Sell
973,245
-785,026
-45% -$2.85M 0.03% 82
2014
Q2 		$7.16M Hold
1,758,271
– – 0.09% 55
2014
Q1 		$9.34M Sell
1,758,271
-886,516
-34% -$4.97M 0.12% 49
2013
Q4 		$14.7M Hold
2,644,787
– – 0.21% 40
2013
Q3 		$11.9M Hold
2,644,787
– – 0.17% 39
2013
Q2 		$11.3M Buy
+2,644,787
New +$13.3M 0.22% 34

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Julian Baker's SGYP Position: Q4 2015 in Review

Julian Baker sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2015, closing a stake of 67,100 shares — an estimated $356K sold.

Julian Baker first reported a position in SGYP in Q2 2013 and held it in 8 quarters. The position peaked at $14.7M in Q4 2013. 127 funds tracked by Wall St. Rank hold SGYP as of Q4 2015.

  • Julian Baker reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2015 after selling out during the quarter.
  • Julian Baker sold 67,100 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2015, an estimated $356K.
  • Julian Baker first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 8 quarters.
  • Julian Baker's Synergy Pharmaceuticals, Inc Common Stock position peaked at $14.7M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2015.

Based on Baker Bros. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.